Search results
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
Motley Fool via Yahoo Finance· 5 days agoImage Source: Getty Images. Here is a head-to-head comparison of these popular healthcare dividend...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 5 days agoDive Insight: Merck currently sells two pneumococcal vaccines. One, dubbed Pneumovax 23, is for...
Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant...
Centers for Disease Control and Prevention· 6 days agoVaccine Effectiveness among Household Contacts
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 2 days agoBooster shots improve immunity Pate urges people to stay up to date with COVID-19 vaccines. The...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 2 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
Morningstar· 5 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 6 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 3 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...